Retention, early dropout and treatment completion among therapeutic community admissions

Drug and Alcohol Review

Volumn 31, Issue 1, 2012, Pages 64-71

  Darke, Shane ^a   Campbell, Gabrielle ^a   Popple, Garth ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b We Help Ourselves (WHOS)   (Australia)

Author keywords

Completion; Correlate; Psychopathology; Retention; Treatment

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; AGED; ARTICLE; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; LIFE EVENT; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; PATIENT; PROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICS; THERAPEUTIC COMMUNITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; LIFE CHANGE EVENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT DROPOUTS; PROSPECTIVE STUDIES; SEX FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; THERAPEUTIC COMMUNITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84855326495     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2011.00298.x     Document Type: Article

References (43)

1. Shand F, Mattick RP. Results from the 4th National Clients of Treatment Service Agencies census: changes in clients' substance use and other circumstances. Aust N Z J Public Health 2002;26:352-7.
2. Bargagli AM, Faggiano F, Amato L, etal. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population. Subst Use Misuse 2006;41:1861-79.
3. Darke S, Ross J, Mills KL, Williamson A, Havard A, Teesson M. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36months findings from the Australian Treatment Outcome Study (ATOS). Addict Behav 2007;32:1897-906.
4. Darke S, Williamson A, Ross J, Teesson M. Residential rehabilitation for the treatment of heroin dependence: sustained heroin abstinence and drug-related problems two years after treatment entrance. Addict Disord Treat 2006;5:9-18.
5. Hubbard RL, Craddock SG, Flynn PM, etal. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997;11:261-78.
6. Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse. 2year outcomes from the National Treatment Outcome Research Study (UK). Addict Behav 2002;27:155-66.
7. Teesson M, Mills KL, Ross J, Darke S, Williamson A, Havard A. The impact of treatment on 3year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008;103:80-8.
8. Darke S, Ross J, Teesson M, etal. Factors associated with 12months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2005;28:255-63.
9. Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS. Recovery from opioid addiction in DATOS. J Subst Abuse Treat 2003;25:177-86.
10. Hser Y. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up. J Addict Disease 2007;26:51-60.
11. Joe GW, Simpson DD, Broome KM. Effects of readiness to change for drug abuse treatment on client retention and assessment of process. Addiction 1998;93:1177-90.
12. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. Patients, programs, services, and outcome. New York: Springer-Vela, 1991.
13. Cecile JS, Alderman AI, Rutherford MJ, McKay JR, Mulvane FD. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend 2001;61:271-80.
14. Keen J, Oliver P, Rowse G, Mathers N. Residential rehabilitation for drug users: a review of 13months' intake to a therapeutic community. Fam Pract 2001;18:545-8.
15. Mulder RT, Frampton CMA, Peka H, Hampton G, Marsters T. Predictors of 3-month retention in a drug treatment therapeutic community. Drug Alcohol Rev 2009;28:366-71.
16. Nuttbrock LA, Rahav M, Rivera JJ, Ng-Mak DS, Link BG. Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatr Serv 1998;49:68-76.
17. Kritz S, Chu M, John-Hull C, Madray C, Louie B, Brown LS. Opioid dependence as a chronic disease: the inter-relationships between length of stay, methadone dose and age on treatment outcome at an urban opioid treatment program. J Addict Disease 2009;28:53-6.
18. Gossop M, Marsden J, Stewart D, Rolfe A. Treatment retention and 1year outcomes for residential programmes in England. Drug Alcohol Depend 1999;57:89-98.
19. Anglin MD, Hser Y, Grella CE. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997;11:308-23.
20. Hser Y, Grella CE, Hsieh S, Anglin MD, Brown B. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend 1999;57:137-50.
21. Condelli WS, DeLeon G. Fixed and dynamic predictors of client retention in therapeutic communities. J Subst Abuse Treat 1993;10:11-16.
22. King AC, Canada SA. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treat 2004;26:189-95.
23. Darke S, Hall W, Heather N, Wodak A, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users: the Opiate Treatment Index. Br J Addict 1992;87:593-602.
24. Lovibond SH, Lovibond P. Manual for the Depression Anxiety Stress Scales. Sydney: Psychological Foundation, 1995.
25. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales, and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
26. Derogatis LR. BSI. Brief Symptom Inventory. Administration, scoring, and procedures manual, 4th edn. Minneapolis: National Computer Systems, 1993.
27. Weathers FW, Litz BT, Huska JA, Keane TM. PTSD Checklist-Civilian version. Boston: National Center for PTSD, Behavioral Science Division, 1994.
28. Degenhardt L, Hall W, Korten A, Morgan V, Jablensky A. Use of a brief screening instrument for psychosis. Results of an ROC analysis NDARC Technical Report, No. 210. Sydney: University of New South Wales, 2005.
29. Andrews G, Hall W, Teesson M, Henderson S. The mental health of Australians: national survey of mental health and wellbeing. Canberra: Commonwealth Department of Health and Aged Care, 1999.
30. SPSS Inc. PASW Statistics, 18.0. Chicago: SPSS Inc., 2009.
31. Campbell G, Darke S, Popple G. Characteristics of clients admitted to WHOS therapeutic community AOD treatment services 2002-2009. National Drug and Alcohol Research Centre Technical Report No. 311. Sydney: University of New South Wales, 2010.
32. Finney JW, Hahn AC, Moos RH. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction 1996;91:1773-96.
33. Tiet QQ, Ilgen MA, Byrnes HF, Harris AHS, Finney JW. Treatment setting and baseline substance use severity interact to predict patients' outcomes. Addiction 2007;102:432-40.
34. D'Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bargagli AM. Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage. Drug Alcohol Depend 1998;52:167-71.
35. Ross J, Teesson M, Darke S, etal. Short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addict Disord Treat 2006;5:133-44.
36. Deleon G, Melnick G, Cleland C. Client matching: a severity-treatment intensity paradigm. J Addict Dis 2008;27:99-111.
37. Ross J, Teesson M, Darke S, etal. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005;24:411-18.
38. Yates R. Different strokes for different folks: results of a small study comparing characteristics of a therapeutic community population with a community drug project population. Int J Ther Communities 2008;29:44-56.
39. Darke S, Mills KL, Ross J, Teesson M, Williamson A, Havard A. Patterns of major depression and drug-related problems amongst heroin users across 36months. Psychiatr Res 2009;166:7-14.
40. Darke S, Kaye S, McKetin R, Duflou J. The major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008;27:253-62.
41. Gibson A, Day C, Degenhardt L. The impact of illicit drug market changes on health agency operations in Sydney, Australia. J Subst Abuse Treat 2005;28:35-40.
42. Day C, Collins L, Degenhardt L, Thetford C, Maher L. Reliability of heroin users' reports of drug use behaviour using a 24month timeline follow-back technique to assess the impact of the Australian heroin shortage. Addict Res Theory 2004;5:433-43.
43. Jackson CT, Covell NH, Frisman LK, Essock SM. Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. J Dual Diagnosis 2004;1:49-63.